California Pharmacy Board Delays Deadline for Drug Tracking Law
|
|
The California Board of Pharmacy yesterday to delay until 2011, a law that all drugs are sold electronically seized in the drug producers in the pharmacy, the New York Times reported. The polling came in response to complaints filed by other manufacturers, distributors and retailers, who said they could not, for Jan. 1, 2009, at a time and would have led to halt the sale medicines in California, and not as a violation of the rule of law (Pollack, New York Times, 3 / 26). The law, passed in 2004, requires that the monitoring systems, the month of January 1, 2007, the legislature, but in California, 2006, the deadline extended until January 1, 2009. If the Legislature moved the rendez-2006, but also the more stringent restrictions that the mandate of the electronics industry to install readers to track the serial numbers on each drug at a central point in the manufacture, distribution and sale of process (California Healthline, 3 / 25). Ronald Bone - Senior Vice President of McKesson Pharmaceutical, a distributor of drugs - only 100 of the 650 people interviewed by other manufacturers McKesson would be able to establish a system to monitor a drug, Jan. 1, 2009, deadline. Pharmacies and wholesalers also said they could not install the software and equipment necessary for reading the serial numbers, she knew what other systems have been reached with manufacturers (New York Times, 3 / 26 ). Other flight attendants were concerned that, if the producers do not have enough time to communicate with the law, it could be implemented very badly, or they could refuse to sell their drugs at California ( Coll clubs, San Francisco Chronicle, 3 / 26). William Powers, the chairman of the Board of Pharmacy, said in a letter yesterday that the development of Radio Frequency Identification technology for the drug had deteriorated during the six to 18 months and would be ” very useful extra time (East Bay Business Times, 3 / 25). In addition, the FDA has indicated that it would be a version of the standardized system for granting identification numbers to drugs, in March 2010, a timetable, California, for the federal government and using the same standards. Drug makers strongly opposed to the possibility of identifying countries with different standards. The legislature is expected that the amendments made to the discussion of the law before the end of this year |